Topic: Brca

Dr. McCullough emphasizes that the "golden window" for COVID-19 treatment is the first three days of symptoms. He cites a new paper in the Medical Science Monitor regarding the success of early intervention in preventing hospitalization. He notes a growing number of academic physicians are privately reaching out to support his stance as they witness vaccine failures and injuries firsthand.

Pathologist Dr. Ryan Cole discusses an observed uptick in aggressive cancers and the reactivation of stable cancers post-vaccination. He explains the biological mechanism involving the p53 "guardian of the genome" and how the spike protein may interfere with tumor suppressor genes. The segment calls for federal funding to investigate these oncological signals.

Recent studies suggest the vaccine spike protein may interact with cancer-producing genes like BRCA and P53. The FDA has issued warnings regarding myocarditis and Guillain-Barré syndrome following vaccination. Dr. Peter McCullough also addresses reports of severe menstrual abnormalities and uterine bleeding in women, attributing them to the distribution of spike proteins to reproductive tissues.